↩ back to the box





8 news of last week on Startups
body {
width:100% !important;
-webkit-text-size-adjust:100%;
-ms-text-size-adjust:100%;
margin:0;
padding:0;
}

body,table,td,p,a,li,blockquote{
-ms-text-size-adjust:100%;
-webkit-text-size-adjust:100%;
}

.ReadMsgBody{
width:100%;
}.ExternalClass {width:100%;}.ExternalClass, .ExternalClass p, .ExternalClass span, .ExternalClass font, .ExternalClass td, .ExternalClass div {line-height: 100%;}#backgroundTable {margin:0; padding:0; width:100% !important; line-height: 100% !important; background:#f2f2f2;}img {
outline:none;
text-decoration:none;
-ms-interpolation-mode: bicubic;
}
a img {border:none;}
.image_fix {display:block;}p {
font-family: "Verdana";
font-size: 13px;
line-height: 150%;
margin: 1em 0;
padding: 0;
}h1,h2,h3,h4,h5,h6{
margin:0;
padding:0;
}h1 {
color:#2f2f2f !important;
display:block;
font-family:Verdana;
font-size:24px;
font-style:normal;
font-weight:normal;
line-height:125%;
letter-spacing:normal;
margin:0;

text-align:left;
}h2 {
color:#2f2f2f !important;
display:block;
font-family:Verdana;
font-size:18px;
font-style:normal;
font-weight:normal;
line-height:125%;
letter-spacing:normal;
margin:0;

text-align:left;
}h3 {
color:#2f2f2f !important;
display:block;
font-family:Verdana;
font-size:16px;
font-style:normal;
font-weight:normal;
line-height:125%;
letter-spacing:normal;
margin:0;

text-align:left;
}table td {border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt;}table { border-collapse:collapse; mso-table-lspace:0pt; mso-table-rspace:0pt; }a {
color:#557fae;
word-wrap:break-word;
}
#outlook a {padding:0;}
.yshortcuts { color:#557fae; }

#wysija_wrapper {
background:#f2f2f2;
color:#959595;
font-family:"Verdana";
font-size:13px;
-webkit-text-size-adjust:100%;
-ms-text-size-adjust:100%;

}

.wysija_header_container {
mso-border-right-alt: 0;
mso-border-left-alt: 0;
mso-border-top-alt: 0;
mso-border-bottom-alt: 0;

}

.wysija_block {
mso-border-right-alt: 0;
mso-border-left-alt: 0;
mso-border-top-alt: 0;
mso-border-bottom-alt: 0;
background:#ffffff;
}

.wysija_footer_container {
mso-border-right-alt: 0;
mso-border-left-alt: 0;
mso-border-top-alt: 0;
mso-border-bottom-alt: 0;

}

.wysija_viewbrowser_container, .wysija_viewbrowser_container a {
font-family: "Verdana" !important;
font-size: 12px !important;
color: #314f71 !important;
}
.wysija_unsubscribe_container, .wysija_unsubscribe_container a {
text-align:center;
color: #557fae !important;
font-size:12px;
}
.wysija_viewbrowser_container a, .wysija_unsubscribe_container a {
text-decoration:underline;
}
.wysija_list_item {
margin:0;
}@media only screen and (max-device-width: 480px), screen and (max-width: 480px) {a[href^="tel"], a[href^="sms"] {
text-decoration: none;
color: #557fae;pointer-events: none;
cursor: default;
}

.mobile_link a[href^="tel"], .mobile_link a[href^="sms"] {
text-decoration: default;
color: #557fae !important;
pointer-events: auto;
cursor: default;
}body, table, td, p, a, li, blockquote { -webkit-text-size-adjust:none !important; }body{ width:100% !important; min-width:100% !important; }
}@media only screen and (min-device-width: 768px) and (max-device-width: 1024px), screen and (min-width: 768px) and (max-width: 1024px) {a[href^="tel"],
a[href^="sms"] {
text-decoration: none;
color: #557fae;pointer-events: none;
cursor: default;
}

.mobile_link a[href^="tel"], .mobile_link a[href^="sms"] {
text-decoration: default;
color: #557fae !important;
pointer-events: auto;
cursor: default;
}
}

@media only screen and (-webkit-min-device-pixel-ratio: 2) {
}@media only screen and (-webkit-device-pixel-ratio:.75){}
@media only screen and (-webkit-device-pixel-ratio:1){}
@media only screen and (-webkit-device-pixel-ratio:1.5){}













Display problems? View this newsletter in your browser.



































Weekly Newsletterabout the lastStartups and Investors news
























10x Genomics Bags $35M in Series D Extension10X Genomics7068 Koll Center Parkway, Suite 401Pleasanton, CA 94566925-401-7300http://10xgenomics.com/Key contactNameTitleSerge SaxonovCEOPLEASANTON, CA, 10x Genomics today announced $35 million in funding as an extension of its Series D financing led by Meritech Capital.10x Genomics today announced $35 million in funding as an extension of its Series D financing. The round was led by Meritech Capital with Fidelity and Wells Fargo participating. …
Read more.











Cedar Gate Receives Minority InvestmentCedar GateOne Sound Shore Drive, Suite 300Greenwich, CT 06830203-930-5500www.cedargate.comKey contactNameTitleDavid B. Snow Jr.CEOGREENWICH, CT, Value-based care performance management and operating company, has accepted a strategic minority investment in the company from Ascension Ventures.Cedar Gate Technologies a leading value-based care performance management and operating company, today announced it has accepted a strategic minority investment in the company from Ascension Ventures.Ascension Ventures …
Read more.
























Humatics Raises $28M in Series A1 FinancingHumatics101 Main Street, Suite 1400Cambridge, MA 02142617-401-2419http://site.humatics.com/Key contactNameTitleDavid MindellCEO and Co-FounderWALTHAM, MA, Pioneer in microlocation products and software, has raised $28 Million in a Series A1 financing.Humatics Corporation, the pioneer in microlocation products and software, has raised $28 Million in a Series A1 financing. Tenfore Holdings, an investment management firm that provides operational value-added resources to growth-stage companies, led the …
Read more.











Boom Supersonic Snares $100M in Series BBoom Supersonic12850 E. Control TowerEnglewood, CO 80112720-598-2666http://boomsupersonic.com/Key contactNameTitleBlake SchollCEOLONG BEACH, CA, Boom Supersonic has completed a $100 million Series B capital raise.Sunstone Venture Capital Fund has announced its investment in the recently completed $100 million Series B raise by Boom Supersonic. The Denver based aerospace startup is seeking to make supersonic air travel dramatically more accessible worldwide. Sunstone, a diversified …
Read more.
























Schrodinger Closes $85M FinancingSchrodinger120 West 45th Street, 17th FloorNew York, NY 10036212-295-5800http://www.schrodinger.com/Key contactNameTitleRamy FaridCEONEW YORK, NY, Schrodinger announced the closing of an $85 million financing.Schrodinger, a privately held company revolutionizing drug discovery through advanced molecular simulations, today announced the closing of an $85 million financing to support continued growth and innovation of its computational platform and expansion of its drug discovery pipeline.The Bill …
Read more.











WithMe Health Raises $20M RoundWithMe Health800 Boylston St., Suite 2904Boston, MA 02116http://withme.health/Key contactNameTitleChris PriceCEOBOSTON, MA, New medication guidance company, announced today that it raised a $20 million round of financing from Oak HC/FT.WithMe Health (WithMe), a new medication guidance company, announced today that it raised a $20 million round of financing from Oak HC/FT, a premier venture growth-equity fund investing in tech-enabled healthcare and …
Read more.











Pear Therapeutics Completes $64M Series CPEAR Therapeutics745 Atlantic Ave.Boston, MA 02111646-932-2774https://peartherapeutics.com/Key contactNameTitleCorey McCannCEOBOSTON, MA, Pear Therapeutics successfully closed a $64 million Series C financing led by Temasek.Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that it has successfully closed a $64 million Series C financing led by Temasek, and joined by other existing investors including Novartis, 5AM Ventures, Arboretum Ventures, Jazz Venture …
Read more.
























Ribon Therapeutics Raises $65M Series BRibon Therapeutics99 Hayden Avenue, Building D, Suite 100Lexington, MA 02421617-914-8700http://www.ribontx.com/Key contactNameTitleVictoria RichonCEOLEXINGTON, MA, Biotechnology company announced the closing of a $65 million Series B financing, led by the Novartis Venture Fund.Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions, today announced the closing of a $65 million Series B financing. Proceeds will …
Read more.

































































Unsubscribe - Edit your subscriptionVia Piemonte, 11
Ascoli Piceno (AP) - 63100
Italy